Latest Diamyd Medical ADR (DMYDY) Headlines M
Post# of 1
Posted On: 03/09/2014 3:11:03 PM
Latest Diamyd Medical ADR (DMYDY) Headlines
Mertiva AB: Mertiva, former Diamyd Medical, will be listed at NasdaqOMX Nordic Stockholm under its new company name Mertiva Aktiebolag and new short name MERT
Business Wire - Fri May 03, 7:08AM CDT
Regulatory News:
Diamyd Medical Changes Name to Mertiva
Business Wire - Tue Apr 23, 5:18AM CDT
Regulatory News:
Bulletin from Extraordinary General Meeting of Diamyd Medical AB
Business Wire - Tue Apr 23, 5:13AM CDT
Regulatory News:
Diamyd Medical: Quarterly Report II 12/13
Business Wire - Wed Mar 27, 2:48AM CDT
Regulatory News:
Information about Summons to Extraordinary General Meeting of Diamyd Medical AB
Business Wire - Thu Mar 21, 2:46AM CDT
Regulatory News:
Extraordinary General Meeting of Diamyd Medical AB Cancelled
Business Wire - Wed Feb 27, 1:49AM CST
Regulatory News:
Diamyd announces settlement of agreement by major shareholders
M2 - Tue Feb 19, 5:06AM CST
Pharmaceutical development company Diamyd Medical AB (STO
IAMB>ST)(Pink SheetsMYDY) announced on Monday that its shareholders, representing a majority of the votes in the company, have reached an agreement to distribute the parent company's excess cash to the shareholders and to convert all shares to series B shares with equal voting power.
Diamyd Medical: Diamyd's major shareholders reach agreement
Business Wire - Mon Feb 18, 1:14AM CST
Regulatory News:
Extraordinary General Meeting to Address the Proposal by a Group of Shareholders That Diamyd Medical Enter into Immediate Liquidation
Business Wire - Mon Feb 11, 1:45PM CST
Regulatory News:
Diamyd Medical: New Clinical Study with Diamyd's Diabetes Vaccine
Business Wire - Wed Jan 30, 1:53AM CST
Regulatory News:
Diamyd Medical: Recombinant vaccine from Protein Sciences receives FDA approval
Business Wire - Thu Jan 17, 1:54AM CST
Regulatory News:
Mertiva AB: Mertiva, former Diamyd Medical, will be listed at NasdaqOMX Nordic Stockholm under its new company name Mertiva Aktiebolag and new short name MERT
Business Wire - Fri May 03, 7:08AM CDT
Regulatory News:
Diamyd Medical Changes Name to Mertiva
Business Wire - Tue Apr 23, 5:18AM CDT
Regulatory News:
Bulletin from Extraordinary General Meeting of Diamyd Medical AB
Business Wire - Tue Apr 23, 5:13AM CDT
Regulatory News:
Diamyd Medical: Quarterly Report II 12/13
Business Wire - Wed Mar 27, 2:48AM CDT
Regulatory News:
Information about Summons to Extraordinary General Meeting of Diamyd Medical AB
Business Wire - Thu Mar 21, 2:46AM CDT
Regulatory News:
Extraordinary General Meeting of Diamyd Medical AB Cancelled
Business Wire - Wed Feb 27, 1:49AM CST
Regulatory News:
Diamyd announces settlement of agreement by major shareholders
M2 - Tue Feb 19, 5:06AM CST
Pharmaceutical development company Diamyd Medical AB (STO
IAMB>ST)(Pink SheetsMYDY) announced on Monday that its shareholders, representing a majority of the votes in the company, have reached an agreement to distribute the parent company's excess cash to the shareholders and to convert all shares to series B shares with equal voting power. Diamyd Medical: Diamyd's major shareholders reach agreement
Business Wire - Mon Feb 18, 1:14AM CST
Regulatory News:
Extraordinary General Meeting to Address the Proposal by a Group of Shareholders That Diamyd Medical Enter into Immediate Liquidation
Business Wire - Mon Feb 11, 1:45PM CST
Regulatory News:
Diamyd Medical: New Clinical Study with Diamyd's Diabetes Vaccine
Business Wire - Wed Jan 30, 1:53AM CST
Regulatory News:
Diamyd Medical: Recombinant vaccine from Protein Sciences receives FDA approval
Business Wire - Thu Jan 17, 1:54AM CST
Regulatory News:
(0)
(0)Diamyd Medical Adr (DMYDY) Stock Research Links
Scroll down for more posts ▼